R&D Articles - Pharmaceutical Executive

ADVERTISEMENT

R&D Articles
Corporate strategies and tactics for more effective drug development.

How Evidence Based Medicine is Impacting Global Clinical and Reimbursement Practices

March 24, 2009

Evidence-based medicine is fast becoming one of the key concepts in clinical and reimbursement practices in the developed world

Transforming Clinicians into Industry Leaders

February 13, 2009

Could physician behavior have a positive impact on Drug Development?

Vaccines for All

February 1, 2009

The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.

Pfizer Sheds More Staff

January 14, 2009

Sales reps aren't the only ones heading for the unemployment line - Pfizer is eliminating researcher positions as fewer drugs are making it to development. But could streamlining the crux of drug R&D cause more harm than good?

Insuring Global Clinical Trials

January 9, 2009

As global regulators set up rules for liability insurance for clinical trials, the playing field has grown complex for sponsors. This article reviews the key issues and offers a look at how European, Asian, and Latin American countries handle clinical trial insurance.

Rethinking the Sponsor-Investigator Relationship

January 6, 2009

When it comes to working with clinical research sites, pharmaceutical companies should take a page out of the automakers' playbook

Coping With Kubin

January 6, 2009

The debate over gene sequence patents is leaving investors lost and confused. These strategies will help them find their way

Site Activation: The Key to More Efficient Clinical Trials

December 12, 2008

A new study of hundreds of thousands of clinical trial records reveals that the overall length of a trial is directly related to how long it takes to activate the study sites - and that most companies are wasting precious weeks and even months in activation. Here's how to improve your performance.

The 2008 Pipeline Report

December 1, 2008

We scrub industry's pipeline to find the drugs that everyone will be talking about in 2009 and beyond

ADVERTISEMENT

Click here